Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition

Dig Liver Dis. 2005 Jan;37(1):44-50. doi: 10.1016/j.dld.2004.07.018.

Abstract

Introduction: Probiotic bacteria have to survive passage through the gastrointestinal tract. In this placebo-controlled double-blind study, the effect of Lactobacillus plantarum 299v on the faecal flora was studied with and without gastric acid inhibition.

Methods: Thirty-two healthy volunteers were given pantoprazole (40 mg/day) or placebo for 3 weeks from week 2 until week 4. In addition, from week 3 until week 4, L. plantarum 299v in an oatmeal-fermented drink (10(9) CFU/ml) was given twice daily to both groups. From each healthy volunteer, faecal samples were collected at the end of week 1, 2, 4 and 8 (4 weeks after cessation of L. plantarum 299v and pantoprazole/placebo). Several aerobically and anaerobically growing bacteria were counted and short chain fatty acid concentrations were determined.

Results: In both the pantoprazole and the placebo group, median lactobacilli counts increased significantly in week 4 compared to week 1 (from log 4.5 to 8.0 CFU/g faeces in pantoprazole and from log 4.2 to 7.7 CFU/g faeces in placebo group) and decreased significantly in week 8 (to log 4.5 CFU/g faeces in pantoprazole and log 4.3 CFU/g faeces in placebo group). These lactobacilli were identified as L. plantarum 299v. No significant differences were observed in all other bacterial counts and short chain fatty acid concentrations.

Conclusions: The comparable increase of faecal lactobacilli counts in both the pantoprazole and the placebo-treated group demonstrates that L. plantarum 299v survives passage through the gastrointestinal tract irrespective of gastric acidity. The increment of the intra-gastric pH in combination with L. plantarum 299v did not modulate bacterial composition and/or the production of short chain fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Benzimidazoles / pharmacology*
  • Double-Blind Method
  • Fatty Acids / analysis
  • Feces / microbiology*
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Lactobacillus plantarum / drug effects*
  • Male
  • Middle Aged
  • Omeprazole / analogs & derivatives*
  • Omeprazole / pharmacology*
  • Pantoprazole
  • Probiotics / therapeutic use
  • Proton Pump Inhibitors*
  • Stomach / chemistry*
  • Sulfoxides / pharmacology*

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Benzimidazoles
  • Fatty Acids
  • Proton Pump Inhibitors
  • Sulfoxides
  • Pantoprazole
  • Omeprazole